Ablation device with ionically conductive balloon

Information

  • Patent Grant
  • 9603659
  • Patent Number
    9,603,659
  • Date Filed
    Friday, September 14, 2012
    11 years ago
  • Date Issued
    Tuesday, March 28, 2017
    7 years ago
Abstract
Devices, systems, and methods for performing ablation therapy on body tissue are disclosed. An example ablation device for treating body tissue includes an ionically conductive balloon and a radio-frequency electrode that delivers RF energy into a distal section of the balloon. The balloon can have a composite structure with a non-conductive section and a conductive section. A method for fabricating a semi-permeable ablation balloon using ionizing radiation and an etching process is also disclosed.
Description
TECHNICAL FIELD

The present disclosure relates generally to an ablation device. More specifically, the present disclosure pertains to an ablation device including an ionically conductive balloon for performing radio-frequency ablation therapy on body tissue.


BACKGROUND

The treatment of cardiac arrhythmias is sometimes performed in conjunction with an ablation catheter inserted into a chamber of the heart or in one of the vessels leading into or from the heart. In the treatment of atrial fibrillation, for example, a radio frequency (RF) ablation catheter equipped with a number of electrodes can be brought into contact with cardiac tissue for creating one or more ablation points along the tissue. During ablation, an RF generator supplies electrical energy to the electrodes, generating an electric field in the tissue. The resulting heat from this electric field forms a controlled lesion that blocks the electrical impulses from being conducted through the tissue and serves to promote the normal conduction of electrical impulses through the proper electrical pathway within the heart.


In certain catheter ablation procedures, it may be difficult to electrically isolate the tissue to be treated. In the treatment of paroxysmal atrial fibrillation, for example, it is often tedious and time consuming to isolate the pulmonary veins using an ablation catheter having an ablation electrode that directly contacts the tissue. Moreover, the ablations created by some ablation electrodes can cause dehydration in the tissue, which can result in scarring and calcification as the lesion heals. Due to the discrete nature of the ablation points, there is also the potential for leaving small gaps of electrically conductive tissue in the ablation line that may continue to initiate points of arrhythmias.


SUMMARY

The present disclosure relates generally to an ablation device including an ionically conductive balloon for performing radio-frequency ablation therapy on body tissue.


In Example 1, an ablation device for treating body tissue, comprises: an elongate shaft having a proximal section, a distal section, and at least one fluid lumen configured to receive an electrically conductive fluid; an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the at least one fluid lumen for actuating the balloon between a collapsed state and an expanded state, wherein the balloon comprises a composite structure having a proximal balloon section including a first polymeric material and a distal balloon section including a second polymeric material different from the first material; and at least one electrode located within the interior space of the balloon.


In Example 2, the ablation device according to Example 1, wherein the first polymeric material is a hydrophobic polymer.


In Example 3, the ablation device according to any of Examples 1-2, wherein the second polymeric material is a hydrophilic polymer.


In Example 4, the ablation device according to any of Examples 1-3, further comprising at least one additional fluid lumen for recirculating fluid through the device.


In Example 5, the ablation device according to any of Examples 1-4, wherein, in the expanded state, the balloon is conically shaped.


In Example 6, the ablation device according to any of Examples 1-5, wherein the distal section of the balloon is invaginated.


In Example 7, the ablation device according to any of Examples 1-6, wherein the distal section of the balloon is semi-permeable.


In Example 8, the ablation device according to any of Examples 1-7, wherein a thickness of the balloon tapers along a length of the balloon from the proximal balloon section to the distal balloon section.


In Example 9, the ablation device according to any of Examples 1-8, wherein the balloon comprises a multi-layered structure.


In Example 10, the ablation device according to any of Examples 1-9, further comprising a temperature sensing element coupled to the distal section of the balloon.


In Example 11, the ablation device according to any of Examples 1-10, further comprising at least one electrocardiogram sensor coupled to the distal section of the balloon.


In Example 12, the ablation device according to any of Examples 1-11, further comprising a spring-actuated plunger assembly configured to bias the balloon in the collapsed state.


In Example 13, the ablation device according to Example 12, wherein the plunger assembly comprises a plunger mechanism and a spring configured to bias the plunger mechanism against the balloon.


In Example 14, the ablation device according to Example 13, wherein the plunger mechanism includes a plunger shaft and an atraumatic tip.


In Example 15, the ablation device according to Example 14, wherein the plunger shaft is slidably disposed within the catheter shaft and the electrode.


In Example 16, an ablation device for treating body tissue comprises: an elongate shaft having a proximal section, a distal section, and at least one fluid lumen configured to receive an electrically conductive fluid; an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the at least one fluid lumen for actuating the balloon between a collapsed state and an expanded state; at least one electrode located within the interior space of the balloon; and a spring mechanism configured to bias the balloon in the collapsed state.


In Example 17, a method of forming a balloon of an ablation catheter, the balloon having a proximal section and a distal section, the method comprising: masking the proximal section of the balloon; irradiating the distal section of the balloon with an ionizing radiation source; etching the balloon to form a plurality of micropores through the distal section of the balloon; and securing the balloon to a catheter.


In Example 18, the method according to Example 17, wherein the ionizing radiation source comprises an argon ion source.


In Example 19, the method according to any of Examples 17-18, wherein the proximal section of the balloon comprises a hydrophobic polymer and the distal section of the balloon comprises a hydrophilic polymer.


In Example 20, the method according to any of Examples 17-19, wherein a pore size of the micropores is between about 0.1 microns to 5 microns in diameter.


In Example 21, a system for ablating body tissue comprises: an RF generator including a switching mechanism operable between a first position and a second position; a fluid source including a supply of electrically conductive fluid; and an ablation device, the ablation device including an elongate shaft having a proximal section, a distal section, and at least one fluid lumen; an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the fluid source for actuating the balloon between a collapsed state and an expanded state; a first electrode disposed within the interior space of the balloon and electrically coupled to the RF generator, the first electrode configured for supplying a first RF electrical field through the balloon and into the body tissue when operating in the first position; a second electrode coupled to a distal end portion of the elongate shaft and electrically coupled to the RF generator, the second electrode configured for supplying a second RF electric field directly into the tissue when operating in the second position.


In Example 22, the system according to Example 21, wherein the balloon comprises a composite structure having a proximal balloon section including a hydrophobic polymeric material and a distal balloon section including a hydrophilic polymeric material.


In Example 23, the system according to any of Examples 21-22, wherein, in the expanded state, the balloon is conically shaped.


In Example 24, the system according to any of Examples 21-23, wherein the distal section of the balloon is invaginated.


In Example 25, the system according to any of Examples 21-24, wherein the distal section of the balloon is semi-permeable.


In Example 26, the system according to any of Examples 21-25, wherein a thickness of the balloon tapers along a length of the balloon from a proximal balloon section to a distal balloon section.


In Example 27, the system according to any of Examples 21-26, wherein the balloon comprises a multi-layered structure.


In Example 28, the system according to any of Examples 21-27, further comprising a spring-actuated plunger assembly configured to bias the balloon in the collapsed state.


In Example 29, a method for performing ablation therapy on the body of a patient comprises: advancing an ablation device to a target body tissue region, the ablation device including an inflatable balloon coupled to an elongate shaft, a first electrode disposed within an interior space of the balloon, and a second electrode located outside of the balloon; injecting an electrically conductive fluid into the interior section of the balloon and inflating the balloon from a collapsed state to an expanded state within the body; selectively energizing the first electrode and generating a first RF electrical field within the balloon interior; forming at least one ablation lesion within the body tissue using the first RF electrical field; selectively energizing the second electrode and generating a second RF electrical field; and forming at least one ablation lesion within the body tissue using the second RF electrical field.


In Example 30, the method according to Example 29, further comprising an RF generator including a switching mechanism, and wherein selectively energizing the first or second electrodes includes operating the switching mechanism between a first and second switch position.


In Example 31, the method according to any of Examples 29-30, wherein forming at least one ablation lesion within the body tissue using the first RF electrical field includes forming a lesion in the body tissue at a location distal to the elongate shaft.


In Example 32, the method according to any of Examples 29-31, wherein the at least one ablation lesion formed within the body tissue using the first RF electric field is larger than the at least one ablation lesion formed in the body tissue using the second RF electric field.


In Example 33, an ablation device for treating body tissue comprises: an elongate shaft having a proximal section, a distal section, and at least one fluid lumen configured to receive an electrically conductive fluid; an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the at least one fluid lumen for actuating the balloon between a collapsed state and an expanded state; and at least one electrode located within the interior space of the balloon, the at least one electrode configured for transmitting an RF electric field through the balloon and into body tissue in contact with the balloon; wherein the balloon is configured to transmit the RF electric field in a direction distally towards a leading end of the ablation device.


In Example 34, the ablation device according to Example 33, wherein the balloon comprises a composite structure having a proximal balloon section including a hydrophobic polymeric material and a distal balloon section including a hydrophilic polymeric material.


In Example 35, the ablation device according to any of Examples 33-34, wherein, in the expanded state, the balloon is conically shaped.


In Example 36, the ablation device according to any of Examples 33-35, wherein the distal section of the balloon is invaginated.


In Example 37, the ablation device according to any of Examples 33-36, wherein the distal section of the balloon is semi-permeable.


In Example 38, the ablation device according to any of Examples 33-37, wherein a thickness of the balloon tapers along a length of the balloon from a proximal balloon section to a distal balloon section.


In Example 39, the ablation device according to any of Examples 33-38, wherein the balloon comprises a multi-layered structure.


In Example 40, the ablation device according to any of Examples 33-39, further comprising a spring-actuated plunger assembly configured to bias the balloon in the collapsed state.


While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic view of an ablation device in accordance with an illustrative embodiment;



FIG. 2 is a partial cross-sectional view showing the distal section of the ablation device of FIG. 1 in a collapsed state;



FIG. 3 is another partial cross-sectional view showing the distal section of the ablation device of FIG. 1 in an expanded state;



FIG. 4 is a flow diagram showing an example method for fabricating a porous balloon of an ablation device;



FIG. 5 is a perspective view showing an example composite balloon in accordance with an illustrative embodiment;



FIG. 6 is a partial cross-sectional view showing the distal section of an ablation device in accordance with another illustrative embodiment;



FIG. 7 is a partial cross-sectional view showing the distal section of an ablation device in accordance with another illustrative embodiment;



FIG. 8 is a partial cross-sectional view showing the distal section of an ablation device in accordance with another illustrative embodiment;



FIG. 9 is a schematic view of an ablation device in accordance with another illustrative embodiment; and



FIG. 10 is a flow diagram of an illustrative method of performing a cardiac ablation procedure using the ablation device of FIG. 9.





While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.


DETAILED DESCRIPTION


FIG. 1 is a schematic view of an ablation device 10 in accordance with an illustrative embodiment. As shown in FIG. 1, the ablation device 10 includes an elongate shaft 12 having a proximal section 14, a distal section 16, and at least one lumen 18 extending through the shaft 12 between the proximal and distal sections 14, 16. An inflatable ablation balloon 20 coupled to the distal section 16 of the shaft 12 can be inflated at a target location within the body (e.g., within a cardiac vessel) and brought into contact with the body tissue to be treated. In some embodiments, and as further described below, an RF electrode assembly 22 located within an interior portion of the balloon 20 generates an RF electric field that can be used for creating controlled lesions within the tissue. In the treatment of paroxysmal atrial fibrillation, for example, the balloon 20 and the RF electrode assembly 22 can be used for performing electrical isolation within a pulmonary vein to prevent the aberrant conduction of electrical signals within the left side of the heart. The ablation device 10 can also be used for treating other types of cardiac arrhythmias and/or cardiovascular diseases within the body. The ablation device 10 can also be used for treating other conditions commonly performed by ablation devices.


A handle 24 coupled to the proximal section 14 of the shaft 12 can be used by the clinician for manipulating and steering the distal section 16 to a target site within the body for performing an ablation. In some embodiments, the handle 24 includes a fluid port 26 and valve 28 in fluid communication with a source of electrically conductive fluid 30. In some embodiments, for example, the fluid 30 can comprise saline or a solution of saline and a fluoroscopic contrast medium that is both conductive and biocompatible. During an ablation procedure, pressurized fluid 30 can be delivered via the fluid lumen 18 to the interior of the balloon 20, causing the balloon 20 to inflate while also creating an electrical pathway between the electrode 22 and the portion of the balloon 20 in contact with the body tissue to be treated. In some embodiments, multiple fluid ports can be provided to recirculate the fluid 30 through the ablation device 10 as part of a closed-loop system for controlling the temperature within the balloon 20.


In some embodiments, the ablation device 10 further includes a steering mechanism 32 that can be used to mechanically steer the distal section 16 of the shaft 12 within the body. In certain embodiments, for example, the steering mechanism 32 comprises a slider or lever mechanism on the handle 24 that can be actuated by the clinician to engage a number of steering wires located within the shaft 12. During delivery of the device 10 to a target region within the body, the steering mechanism 32 can be engaged to deflect the distal section 16 of the shaft 12, allowing the clinician to better navigate the device 10 through the vasculature.


An RF generator 34 is configured to supply radio-frequency energy to the electrode assembly 22. In some embodiments, the device 10 is configured to operate in a bipolar mode, in which ablation energy supplied by the RF generator 34 flows from one electrode of the electrode assembly 22 to another electrode of the electrode assembly 22 or provided at a different location along the device 10 (e.g., along the distal section 16 of the shaft 12). In other embodiments, the device 10 is configured to operate in a unipolar mode, in which an indifferent electrode (e.g., an electrode patch) is attached to the patient's back or other exterior skin area and ablation energy from the RF generator 34 flows from one electrode of the assembly 22 to the indifferent electrode.



FIG. 2 is a partial cross-sectional view showing the distal section 16 of the ablation device 10 of FIG. 1 in greater detail. As can be further seen in FIG. 2, and in some embodiments, the electrode assembly 22 comprises at least one RF electrode 36 located within an interior space 38 of the balloon 20. The RF electrode 36 is fixedly secured to a distal end 40 of the shaft 12 (e.g., using a suitable adhesive at both ends of the electrode 36), and is electrically coupled to the RF generator 34. In the embodiment of FIG. 2, the RF electrode 36 comprises a metal tubular member made from a suitably conductive metal such as platinum, and is electrically coupled to the RF generator 34 via a number of conductor wires (not shown) located within the shaft 12. The configuration of the RF electrode 36 can vary from that shown, however. For example, the RF electrode 36 can comprise a coil, ring, flat ribbon, or other suitable shape. In some embodiments, the electrode assembly 22 can include multiple electrodes 36 as part of either a bipolar RF ablation system, or as part of a unipolar system with multiple electrodes.


The device 10 includes at least one fluid lumen for transmitting pressurized fluid 30 to the interior space 38 of the balloon 20. In the embodiment of FIG. 2, the device 10 includes a central fluid lumen 18 that extends longitudinally through the shaft 12 and through a portion of the RF electrode 36. In some embodiments, the fluid lumen 18 terminates distally at a number of inflation ports 42 disposed circumferentially about the RF electrode 36. In some embodiments, the same fluid lumen 18 can be used for both inflating and deflating the balloon 20. In other embodiments, separate fluid lumens are used for inflating and deflating the balloon 20. Such a configuration can provide continuous infusion and evacuation of fluid within the balloon 20 to maintain both a controlled operating pressure and temperature within the balloon 20. In one embodiment, multiple fluid lumens within the shaft 12 may permit the electrically conductive fluid 30 to be recirculated through the device 10 during the ablation procedure. The fluid 30 can also include a contrast medium to facilitate visualization of the balloon 20 under fluoroscopy.


In the embodiment of FIG. 2, the balloon 20 is coupled to the distal section 16 of the shaft 12 at or near the distal shaft end 40, and is inflatable from an initial, collapsed position having a low-profile that facilitates traversal of the device 10 through the body, to a second, expanded position that contacts and engages the body tissue to be ablated. In certain embodiments, the balloon 20 has a composite structure formed from different polymeric materials, which helps to direct and focus the RF energy from the RF electrode 36 into the body tissue located at or near a distal end 44 of the balloon 20. In one embodiment, for example, the composite balloon 20 includes a proximal, non-conductive section 46a made from a hydrophobic polymer and a distal, conductive section 46b made from a hydrophilic polymer. The polymer of the non-conductive section 46a can be non-ionically conductive and the polymer of the distal section 46b can be ionically conductive. In some embodiments, for example, the composite balloon structure can comprise a proximal section 46a made from a hydrophobic polyurethane material and a distal section 46b made from a hydrophilic polyurethane material such as TECOPHILIC 60D®, available from Thermedics Polymer Products of Woburn, Mass. TECOPHILIC® is a polyether-based aliphatic polyurethane and exhibits sufficient elasticity so as to be capable of stretching substantially beyond its equilibrium dimensions when the balloon 20 is inflated. Other polymeric materials can also be used to impart differing hydrophilic characteristics to the proximal and distal sections 46a, 46b. As used herein, the term “hydrophilic” indicates that the polymer, when in contact with an aqueous solution, can absorb a quantity of water while still maintaining its structural integrity.


When inflated with the electrically conductive fluid 30, the distal section 46b of the composite balloon 20 is rendered conductive by hydration due to the ionic content of the fluid 30 when the RF energy is supplied to the RF electrode 36. As a result, electrical current is transmitted through the fluid 30 and into the tissue in contact with the distal section 46b of the balloon 20. In some cases, current passes through all areas of the balloon material that are hydrophilic but does not pass through areas of the balloon that are hydrophobic or non-conductive.


The composite balloon structure can be formed using a number of different techniques. For example, the different sections 46a, 46b of the balloon 20 can be formed by separately dip-coating each section of the balloon 20 on a mandrel that has a defined size and shape. The balloon 20 can also be formed using other techniques, such as by spin-coating in a hollow mold or by injection or blow-molding. Another example method for constructing a composite balloon structure having a permeable or semi-permeable distal section is discussed further herein with respect to FIG. 4.


In some embodiments, the device 10 further includes one or more temperature sensing elements that can be used to sense the temperature of fluid 30 within the balloon 20. In certain embodiments, and as shown in FIG. 2, a temperature sensing element 48 such as a thermocouple or thermistor is coupled to the inner surface 50 of the balloon 20 at the distal section 46b. In other embodiments, the temperature sensing element 48 is coupled to an outer surface 52 of the balloon 20 at the distal section 46b, or is coupled to another portion of the balloon 20 or to the shaft 12. In another embodiment, the temperature sensing element 48 is encased within the interior of the balloon material. In some embodiments, multiple temperature sensing elements can be coupled to the inner and/or outer surfaces 50, 52 of the balloon and/or to the shaft 12 for sensing temperature at multiple locations. In various embodiments, a temperature sensor is located on the outer surface of the balloon and/or within the wall of the balloon. Such a configuration can measure the temperature of the tissue undergoing ablation. In these or other embodiments referenced herein, the intensity of ablation therapy (e.g., power) can be automatically modulated based on the measured temperature to limit the temperature of the tissue undergoing ablation. Such a configuration can provide protection from steam pops, where a small gaseous rupture in tissue can otherwise be created by water in the tissue turning into steam when the temperature reaches 1000 C or greater.


In some embodiments, the temperature sensing element 48 senses the temperature of the fluid 30 contained within the interior section 38 of the balloon 20, and is connected to temperature sensing circuitry (e.g., based on a thermometer) located outside of the body. During ablation, the RF generator 34 can be controlled so as to adjust the temperature of the fluid 30 contained in the balloon 20 to a desired temperature. In those embodiments in which multiple fluid ports are utilized for recirculating fluid through the device 10, the flow of fluid can also be controlled based on feedback from the temperature sensing element 48 to maintain the fluid within the balloon 20 at a particular temperature or within a range of temperatures.


One or more electrocardiogram sensors coupled to the balloon 20 can also be used in some embodiments for sensing electrical activity in or near the heart. In the embodiment of FIG. 2, for example, an electrocardiogram sensor 54 is coupled to the inner surface 50 of the balloon 20 at the distal section 46b, allowing the clinician to monitor for the presence of any electrical activity at the target ablation site. In other embodiments, the electrocardiogram sensor 54 is coupled to the outer surface 52 of the balloon 20 at the distal section 46b, or is coupled to another portion of the balloon 20 or shaft 12. In another embodiment, the electrocardiogram sensor 54 is encased within the interior of the balloon material. In some embodiments, multiple electrocardiogram sensors can be coupled to and/or encased within the balloon 20 and/or to the shaft 12 for sensing electrical activity at multiple locations.


A spring actuated plunger assembly 56 can be used to maintain the balloon 20 in a collapsed, low-profile position to facilitate delivery of the device 10 through the body prior to inflating the balloon 20 at the desired target tissue location. In the embodiment of FIG. 2, the assembly 56 includes a plunger mechanism 58 and a spring 60. The spring 60 is located within the interior of the shaft 12 proximal to the RF electrode 36, and is configured to mechanically bias the plunger mechanism 58 in a distal direction towards the distal end 44 of the balloon 20, thus maintaining the balloon 20 in an extended position until inflated.


In some embodiments, the plunger mechanism 58 comprises a plunger shaft 62 slidably disposed within the interior section 38 of the balloon 20 and through a portion of the RF electrode 36. The distal end of the plunger shaft 62 includes an atraumatic tip 64 which, when the plunger mechanism 58 is fully engaged distally, is configured to contact and engage the distal end 44 of the balloon 20 causing the balloon 20 to collapse and assume a low-profile position, as shown. The shape of the tip 64 is curved to conform to the shape of the balloon 20 at the distal end 44. The proximal end of the plunger shaft 62 is coupled to a plunger seal 66, which provides a surface against which the spring 60 engages the plunger shaft 62. A shoulder 68 located within the interior of the shaft 12 proximal to the spring 60 provides a proximal stop to prevent proximal movement of the spring 60 when the spring 60 is compressed.



FIG. 3 is another partial cross-sectional view of the ablation device 10 of FIG. 1, showing the balloon 20 in a second, fully expanded position. As can be further seen in FIG. 3, when pressurized fluid 30 is injected into the interior section 38 of the balloon 20, the fluid pressure exerted against the surface of the plunger seal 66 is configured to overcome the spring bias provided by the spring 60, causing the spring 60 to move to a second, compressed position within the shaft interior. Once the balloon 20 is inflated, the pressure within the interior section 38 of the balloon 20 pushes the plunger assembly 56 in a proximal direction. As a result, the plunger shaft 62 is drawn proximally into the shaft interior, causing the atraumatic tip 64 to disengage from the distal end 44 of the balloon 20.


When the tip 64 disengages from the distal end 44 of the balloon 20, and as shown in FIG. 3, the balloon 20 is configured to expand to its second, expanded position. In some embodiments, the shape of the inflated balloon 20 may vary along its length such that the proximal section 46a of the balloon 20 has a profile and shape that is different from that of the distal section 46b. In the embodiment of FIG. 3, for example, the inflated balloon 20 has a substantially conical shape such that the distal, conductive section 46b of the balloon 20 exposes a relatively large area towards the distal end 44 of the balloon 20. The conical shape of the distal section 46b facilitates contact of the balloon 20 with body tissue located primarily distally of the device 10. The proximal section 46a of the balloon 20, in turn, has a relatively low profile, and thus does not contact the body tissue. In contrast to the distal section 46b, the hydrophobic material of the proximal section 46a also does not conduct with the fluid 30 within the balloon 20.


Although the illustrative balloon 20 in FIG. 3 has a conical shape when expanded, in other embodiments the balloon 20 can have a different shape and/or profile when inflated. Examples of other balloon shapes can include elliptical, spherical, or dumbbell. In some embodiments, the balloon shape can be similar to one of the self-anchoring balloon shapes described in U.S. Pat. No. 7,736,362, the contents of which are incorporated herein by reference in their entirety for all purposes. Other balloon configurations are also possible.


In some embodiments, the distal section 46b of the balloon 20 is semi-permeable, allowing at least some of the pressurized fluid 30 within the interior section 38 of the balloon 20 to seep into the body at or near the target ablation site. In some embodiments, the distal section 46b of the balloon 20 is permeable, allowing the pressurized fluid 30 within the interior section 38 of the balloon 20 to seep into the body at or near the target ablation site. During ablation, the presence of the electrically conductive fluid at this interface region aids in creating an electrical conduit for the electrical field generated by the RF electrode 36, and further serves to cool the ablation site. As the RF energy is applied to the RF electrode 36 inside the balloon 20, the RF energy is transmitted to the tissue in contact with the balloon 20 through the electrically conductive fluid seeping through the balloon 20. The permeability or semi-permeability of the distal section 46b also permits the delivery of an agent or drug contained within the fluid 30. In this manner, the balloon 20 may also act as a drug delivery device by introducing one or more drugs into the conductive fluid 30 and permitting the drugs to pass through the balloon 20 and into the tissue.



FIG. 4 is a flow diagram showing an example method 70 for fabricating a porous balloon. The method 70 may begin generally at block 72, by fabricating a composite balloon having a proximal, non-conductive section and a distal, conductive section. It is noted that in some embodiments the distal section is non-conductive. In certain embodiments, for example, a composite balloon 20 such as that shown in FIGS. 2-3 can be fabricated using a suitable process such as dip-coating, spin-coating, injection molding, or blow-molding. Other fabricating techniques for fabricating a composite balloon can also be utilized.


The balloon material or materials can be selected so as to facilitate further processing steps to create micropores through the balloon material. In some embodiments, for example, the workpiece used to create the composite balloon can be formed from a thermoplastic polymer resin such as polyethylene terephthalate (PET). The thermal and/or chemical characteristics of PET permit subsequent processing steps to be performed on the balloon while maintaining the desired tensile strength and elasticity characteristics of the balloon.


Once the composite balloon has been fabricated, the proximal, non-conductive section of the balloon is masked (block 74), and the distal (e.g., conductive) section of the balloon is irradiated with ions from an ionizing radiation source (block 76).


In one embodiment, the composite balloon is irradiated with Argon atoms from an Argon plasma source. Other suitable ionic radiation sources can also be used to irradiate the distal section of the balloon with ions.


Once irradiated, the balloon is then subjected to a sodium hydroxide (NaOH) etching process for a period of time to produce uniform micropores in the distal section of the balloon (block 78). In certain embodiments, for example, the balloon can be inserted into an etching bath and treated for a period of approximately 10 to 15 minutes until pores of a desired size are formed through the balloon material. The pore size can be controlled by the duration of the ionizing radiation and etching steps, the strength of the ionizing radiation, and the strength of the etching solution. Other factors such as the balloon composition, balloon thickness, as well as other characteristics can also affect the pore size. An example pore size that can be generated using this process can be between about 0.1 microns to about 5 microns in diameter, although other pore sizes greater or smaller are also contemplated. For example, in some cases pores can be up to 20 microns in diameter.


Once the micropores are created in the distal section of the balloon, additional processing steps can then be performed to secure the balloon onto the shaft (block 80). In one embodiment, the balloon can be mounted to the distal end of a shaft, similar to that shown in the illustrative embodiment shown in FIGS. 2-3. The balloon can be secured to the shaft in a variety of ways, including adhesive bonding, thermal bonding, mechanical bonding, screws, winding, or a combination of these.



FIG. 5 is a perspective view showing an example composite balloon 20 that has been treated using the method 70 of FIG. 4. As can be seen in FIG. 5, the distal section 46b of the balloon 20 includes a plurality of micropores 82 which, due to the size and shape of the distal section 46b in its inflated state, face substantially in a distal direction away from the distal end 44 of the balloon 20 in the direction indicated generally by arrow 84. When a steady flow of electrically conductive fluid is provided to the interior section 38 of the balloon 20, at least a portion of the fluid seeps through the micropores 82 and into contact with body tissue located distally of the balloon 20. The proximal section 46a of the balloon 20 is substantially non-porous, and thus prohibits the flow of pressurized fluid through the proximal section 46a.



FIG. 6 is a partial cross-sectional view showing the distal section of an ablation device 86 in accordance with another illustrative embodiment. The ablation device 86 includes an elongate shaft 88 coupled to an inflatable ablation balloon 90. The proximal section of the shaft 88 (not shown) is coupled to an electrically conductive fluid source and an RF generator. In the embodiment of FIG. 6, the distal section 92 of the shaft 88 extends through the interior 94 of the balloon 90, and includes a number of fluid ports 96, 98 for circulating fluid through the balloon interior 94. A first fluid port 96 in fluid communication with a first lumen within the shaft 88 is configured to deliver electrically conductive fluid from an external fluid source into the balloon interior 94. A second fluid port 98 in fluid communication with a return fluid lumen of the shaft 88, in turn, functions as a return port for recirculating heated fluid within the balloon interior 94 to a location outside of the patient's body for cooling.


An electrode assembly 100 disposed within the interior 94 of the balloon 90 is electrically coupled to an RF generator, and is configured to generate an RF electric field for creating controlled lesions within tissue located adjacent to the balloon 90. In some embodiments, and as shown in FIG. 6, the electrode assembly 100 comprises a metal coil RF electrode 102 having a helical shape that extends about a portion of the shaft 88 located within the balloon interior 94. In other embodiments, the RF electrode 102 can comprise a tubular member, ring, flat ribbon, or other suitable shape. In some embodiments, the electrode assembly 100 can include multiple electrodes 102 as part of either a bipolar RF ablation system, or as part of a unipolar system with multiple electrodes.


In the embodiment of FIG. 6, a proximal section 112a of the balloon 90 is coupled to the distal section 92 of the elongate shaft 88. A distal section 112b of the balloon 90, in turn, is coupled to the distal end 108 of the elongate shaft 88. In some embodiments, and as shown in FIG. 6, the distal section 112b of the balloon 90 has an invaginated configuration created by folding or turning a portion of the balloon 90 back upon itself and attaching the distal end 106 of the balloon 90 to an interior surface of the shaft distal end 108. The balloon 90 is inflatable from an initial, collapsed position having a low-profile that facilitates traversal of the device 86 through the body, to a second, expanded position that contacts and engages the body tissue to be ablated. In some embodiments, the balloon 90 has a composite structure formed from different polymeric materials, which helps to direct and focus the RF energy from the RF electrode 100 into body tissue located at or near a distal section 112b of the balloon 90. In one embodiment, for example, the composite balloon 90 includes a proximal, non-conductive section 112a made from a hydrophobic polymer and a distal, conductive section 112b made from a hydrophilic polymer. In some embodiments, for example, the composite balloon structure can comprise a proximal section 112a made from a hydrophobic polyurethane material and a distal section 112b made from a hydrophilic polyurethane material such as TECOPHILIC 60D®. Other polymeric materials can also be used to impart differing hydrophilic characteristics to the proximal and distal sections 112a, 112b, as desired.


When inflated with an electrically conductive fluid, the distal section 112b of the balloon 90 is rendered conductive by hydration due to the ionic content of the fluid when RF energy is supplied to the RF electrode 102. An electrical current is thus transmitted through the fluid and into the tissue in contact with the distal section 112b of the balloon 90. When inflated, the invaginated configuration of the balloon 90 also serves to direct the RF electrical field towards the distal section 112b of the balloon 90.


The ablation device 86 can further include one or more features described with respect to other embodiments, including one or more temperature sensors for sensing the temperature of fluid within or on the surface of the balloon 90, and one or more electrocardiogram sensors for sensing electrical activity in or near the heart. The device 86 can also include other features such as a spring-actuated plunger assembly. In certain embodiments, the balloon 90 can also be made permeable or semi-permeable, allowing at least some of the pressurized fluid within the interior section 94 of the balloon 90 to seep into the body at or near the target ablation site.



FIG. 7 is a partial cross-sectional view showing the distal section of an ablation device 114 in accordance with another illustrative embodiment. The ablation device 114 includes an elongate shaft 116 coupled to an inflatable ablation balloon 118. The proximal section of the shaft 116 is coupled to an electrically conductive fluid source and an RF generator. In the embodiment of FIG. 7, the distal section 120 of the shaft 116 extends through the interior 122 of the balloon 118, and includes a number of fluid ports 124, 126 for circulating fluid through the balloon interior 122. A first fluid port 124 in fluid communication with a first lumen within the shaft 116 is configured to deliver electrically conductive fluid from an external fluid source into the balloon interior 122. A second fluid port 126 in fluid communication with a return fluid lumen within the shaft 116, in turn, functions as a return port for recirculating heated fluid within the balloon interior 122 to a location outside of the patient's body for cooling.


An electrode assembly 128 disposed within the interior 122 of the balloon 118 is electrically coupled to an RF generator, and is configured to generate an RF electric field for creating controlled lesions within tissue located adjacent to the balloon 118. In some embodiments, and as shown in FIG. 7, the electrode assembly 128 comprises a metal coil RF electrode 130 having a helical shape that extends about a portion of the shaft 116 located within the balloon interior 122. In other embodiments, the RF electrode 130 can comprise a tubular member, ring, flat ribbon, or other suitable shape. In some embodiments, the electrode assembly 128 can include multiple electrodes 130 as part of either a bipolar RF ablation system, or as part of a unipolar system with multiple electrodes.


In the embodiment of FIG. 7, a proximal end portion 132 of the balloon 118 is coupled to the distal section 120 of the elongate shaft 118. The balloon 118 is inflatable from an initial, collapsed position having a low-profile that facilitates traversal of the device 114 through the body, to a second, expanded position that contacts and engages the body tissue to be ablated. In some embodiments, and as shown, the thickness of the balloon 118 can taper along a length of the balloon 118 that is generally parallel with the shaft 116 such that the thickness of the proximal section 134a is greater than the thickness of the distal section 134b. In certain embodiments, the thickness of the balloon 118 tapers continuously along the length of the balloon 118 between the proximal and distal sections 134a, 134b. In one embodiment, for example, the balloon 118 may continuously taper from a thickness of between about 5 mils (0.005 inches) to 15 mils (0.015 inches) at or near the location 132 where the proximal section 134a of the balloon 118 attaches to the elongate shaft 116, to a thickness of between about 0.5 mil to 5 mils at or near a distal end portion 136 of the balloon 118.


In other embodiments, the balloon 118 may transition in thickness at one or more discrete locations along the length of the balloon 118 such that the thickness of the proximal section 134a is greater than the thickness of the distal section 134b. In one embodiment, for example, the balloon 118 thickness may transition from a relatively thick configuration at the proximal portion 134a of the balloon 118 to a relatively thin configuration at the distal section 134b of the balloon 118 at a location substantially midway along the length of the balloon 118. The balloon 118 may also stepwise transition in thickness at multiple locations along the proximal and/or distal sections 134a, 136b of the balloon 118. Other configurations are also possible.


The balloon 118 can comprise a hydrophilic polymer that facilitates the transmission of the electromagnetic field generated by the RF electrode 130 through the balloon material and into contact with the tissue. In some embodiments, the balloon 118 comprises a composite structure in which multiple materials are used to transition the balloon 118 from a relatively hydrophobic composition along proximal section 134a of the balloon 118 to a relatively hydrophilic composition along the distal section 134b of the balloon 118. In some embodiments, for example, the composite balloon structure can comprise a proximal section 134a made from a hydrophobic polyurethane material and a distal section 134b made from a hydrophilic polyurethane material such as TECOPHILIC 60D®, as discussed herein. The resulting structure is a composite balloon 118 that transitions both in material composition and in thickness along the length of the balloon 118. During an ablation, this reduction in thickness, (and in some embodiments also a change in material composition) along the length of the balloon 118 causes a greater amount of the electric field generated by the RF electrode 130 to pass through the distal section 134b of the balloon 118, allowing the clinician to target body tissue that is situated distally of the balloon 118.


The ablation device 114 can further include one or more features described with respect to other embodiments herein, including one or more temperature sensors for sensing the temperature of fluid within or on the outer surface of the balloon 118 and/or one or more electrocardiogram sensors for sensing electrical activity in or near the heart. The device 114 can also include other features such as a spring-actuated plunger assembly. In certain embodiments, the balloon 118 can also be made permeable or semi-permeable, allowing at least some of the pressurized fluid within the interior section 122 of the balloon 118 to seep into the body at or near the target ablation site.



FIG. 8 is a partial cross-sectional view showing the distal section of an ablation device 138 in accordance with another illustrative embodiment. The ablation device 138 includes an elongate shaft 140 coupled to an inflatable ablation balloon 142. The proximal section of the shaft 140 is coupled to an electrically conductive fluid source and an RF generator. In the embodiment of FIG. 8, the distal section 144 of the shaft 140 extends through the interior 146 of the balloon 142, and includes a number of fluid ports 148, 150 for circulating fluid through the balloon interior 146. A first fluid port 148 in fluid communication with a first lumen within the shaft 140 is configured to deliver electrically conductive fluid from an external fluid source into the balloon interior 146. A second fluid port 150 in fluid communication with a return fluid lumen within the shaft 140, in turn, functions as a return port for recirculating heated fluid within the balloon interior 146 to a location outside of the patient's body for cooling.


An electrode assembly 152 disposed within the interior 146 of the balloon 142 is electrically coupled to an RF generator, and is configured to generate an RF electric field for creating controlled lesions within tissue located adjacent to the balloon 142. In some embodiments, and as shown in FIG. 8, the electrode assembly 152 comprises a metal coil RF electrode 154 having a helical shape that extends about a portion of the shaft 140 located within the balloon interior 146. In other embodiments, the RF electrode 154 can comprise a tubular member, ring, flat ribbon, or other suitable shape. In some embodiments, the electrode assembly 152 can include multiple electrodes 154 as part of either a bipolar RF ablation system, or as part of a unipolar system with multiple electrodes.


In the embodiment of FIG. 8, a proximal end portion 156 of the balloon 142 is coupled to the distal section 144 of the elongate shaft 140. The balloon 142 is inflatable from an initial, collapsed position having a low-profile that facilitates traversal of the device 138 through the body, and a second, expanded position that contacts and engages the body tissue to be ablated. In some embodiments, and as shown in FIG. 8, the balloon 142 comprises a multi-layered structure having a first layer 158 and a second layer 160. The first layer 158 of the balloon 142 comprises a hydrophilic hydratable, ionically conductive material layer that extends across the entire surface area of the balloon 142, along both a proximal section 162a and a distal section 162b of the balloon 142. In certain embodiments, for example, the first layer 158 comprises a hydrophilic polyurethane material such a TECOPHILIC 60D®. In certain embodiments, the thickness of the first layer 158 is between about 1 mil to 3 mils.


In some embodiments, first layer 158 has a uniform thickness along the entire length of the balloon 142. In other embodiments, the thickness of the first layer 158 may transition in thickness along the length of the balloon 142. For example, in some embodiments, the first layer 158 of the balloon 142 may taper in thickness along the length of the balloon 142 such that the portion of first layer 158 located along the proximal section 162a of the balloon 142 is thicker than the portion of the first layer 158 located along the distal section 162b. The thickness of the first layer 158 can taper either continuously or at one or more discrete locations along the length of the balloon 142. In some embodiments, the thickness of the first layer 158 may transition in thickness from about 3 mils at or near the location where the proximal end portion 156 of the balloon 142 attaches to the elongate shaft 140 to a thickness of about 1 mil at or near the distal end portion 164 of the balloon 142.


The second layer 160 of the balloon 142 comprises a hydrophobic material, and extends across only a portion of the balloon 142. In the embodiment of FIG. 8, for example, the second layer 160 is located along only the proximal section 162a of the balloon 142. In some embodiments, the second layer 160 comprises a hydrophobic polymer mask that is spray-coated onto the first layer 158 during the balloon manufacturing process. Other techniques can also be used for forming the second layer 160, including sputtering, adhesion, or co-extrusion.


In the embodiment of FIG. 8, the thickness of the second layer 160 tapers continuously along its length. In other embodiments, the second layer 160 reduces in thickness at one or more discrete locations along its length. In some embodiments, the thickness of the second layer 160 may transition from between about 5 mils at or near the location where the proximal end portion 156 of the balloon 142 attaches to the elongate shaft 140 to a thickness of about 1 mil at or near the location where the second layer 160 terminates.


During ablation, the presence of the hydrophobic second layer 160 over the first layer 158 of the balloon 142 causes a greater amount of the electrical field generated by the RF electrode 154 to pass through the distal section 162b of the balloon 142, allowing the clinician to target body tissue that is situated distally of the balloon 142. In some cases during ablation, the presence of the hydrophobic second layer 160 over the first layer 158 of the balloon 142 causes the RF current to be concentrated and evenly distributed through only the unmasked hydrophilic distal surface of the balloon, allowing the clinician to target body tissue that is situated distally of the balloon 142.


The ablation device 138 can further include one or more features described with respect to other embodiments, including one or more temperature sensors for sensing the temperature of fluid within or on the surface of the balloon and/or one or more electrocardiogram sensors for sensing electrical activity in or near the heart. The device 138 can also include other features such as a spring-actuated plunger assembly. In certain embodiments, the balloon 142 can also be made permeable or semi-permeable, allowing at least some of the pressurized fluid within the interior 146 of the balloon 142 to seep into the body at or near the target ablation site.



FIG. 9 is a schematic view of an ablation device 166 in accordance with another illustrative embodiment. The ablation device 166 includes an elongate shaft 168 having a proximal section 170, a distal section 172, and at least one lumen 173 extending through the shaft 168 between the proximal and distal sections 170, 172. An inflatable balloon 174 coupled to the distal section 172 of the shaft 168 can be inflated at a target location within the body and brought into contact with the body tissue to be treated. In the embodiment of FIG. 9, the distal section 172 of the shaft 168 extends through an interior 176 of the balloon 174, and includes a number of fluid ports 178, 180 for circulating fluid through the balloon interior 176. A first fluid port 178 in fluid communication with a first lumen within the shaft 168 is configured to deliver electrically conductive fluid from an external fluid source into the balloon interior 176. A second fluid port 180 in fluid communication with a return fluid lumen within the shaft 168, in turn, functions as a return port for recirculating heated fluid within the balloon interior 176 to a location outside of the patient's body for cooling.


An electrode assembly 182 disposed within the interior 176 of the balloon 174 is electrically coupled to an RF generator 34 that can be used to generate an RF electric field for creating controlled lesions within tissue. In the embodiment of FIG. 9, the electrode assembly 182 includes a first electrode 184 and a second electrode 186. The first electrode 184 comprises a metal coil RF electrode having a helical shape that extends about a portion of the shaft 168 located within the balloon interior 176. In other embodiments, the first electrode 184 can comprise a tubular member, ring, flat ribbon, or other suitably shaped electrode. The second electrode 186, in turn, is coupled to the distal end portion 188 of the elongate shaft 168, and is located outside of the balloon 174 and directly contacts the body tissue to be ablated.


In some embodiments, the RF generator 34 includes a switch 190 for selectively activating either the first electrode 184 or the second electrode 186. In one embodiment, and as shown, the switch 190 includes a first electrical wire 192 electrically coupled to the first electrode 184 and a second electrical wire 194 electrically coupled to the second electrode 186. During an ablation procedure, the ability to switch back and forth between the first and second electrodes 184, 186 allows the operator to adjust between providing ablation over a relatively large area via conduction through the balloon 174 or over a relatively small, focused area via the second electrode 186, which is in direct contact with the tissue and which has a smaller contact surface area than the balloon 174.


In the embodiment of FIG. 9, a proximal section 196a of the balloon 174 is coupled to the distal section 172 of the elongate shaft 168. A distal section 196b of the balloon 174, in turn, is coupled to the distal end 188 of the elongate shaft 168. In certain embodiments, the balloon 166 has a composite structure formed from different polymeric materials. In one embodiment, for example, the composite balloon 166 includes a proximal, non-conductive section 196a made from a hydrophobic polymer and a distal, hydratable ionically conductive section 196b made from a hydrophilic polymer. In some embodiments, for example, the composite balloon structure can comprise a proximal section 196a made from a hydrophobic polyurethane material and a distal section 196b made from a hydrophilic polyurethane material such as TECOPHILIC 60D®. Other polymeric materials can be used to impart differing hydrophilic characteristics to the proximal and distal sections 196a, 196b.


When inflated with an electrically conductive fluid, the distal section 196b of the balloon 174 is rendered conductive by hydration due to the ionic content of the fluid when the RF energy is supplied to the first RF electrode 184. As a result, electrical current is transmitted through the fluid and into the tissue in contact with the distal section 196b of the balloon 174.


The ablation device 166 can further include one or more features described with respect to other embodiments, including one or more temperature sensors for sensing the temperature of fluid within the balloon or on the surface of the balloon at the balloon-tissue interface, and one or more electrocardiogram sensors for sensing electrical activity in or near the heart. The device 166 can also include other features such as a spring-actuated plunger assembly. In certain embodiments, the balloon 174 can also be made semi-permeable, allowing at least some of the pressurized fluid within the interior section 176 the balloon 174 to seep into the body at or near the target ablation site.



FIG. 10 is a flow diagram of an illustrative method 198 of performing an ablation procedure of using an ablation device. FIG. 10 may represent, for example, several example steps that can be used in conjunction with the ablation device 166 of FIG. 9 for performing ablation on cardiac tissue. The method 198, however, can be performed using any of the ablation devices described herein, and can be used for performing other types of ablation therapy. In one embodiment, for example, the method 198 can be used for performing ablation therapy on brain tissue for treating neurological disorders such as Parkinson's disease.


To perform the therapy, a clinician inserts the ablation device 166 into the lumen of a guide catheter, and advances the ablation device 166 to a region in or near the heart to be treated (block 200). In the treatment of paroxysmal atrial fibrillation, for example, the clinician may insert the guide catheter and ablation device into a main vein or artery (e.g., a femoral artery), and advance the assembly through the vasculature into position within a heart chamber or cardiac vessel to be treated (e.g., a pulmonary vein). In some embodiments, a steering mechanism within the guide catheter or within the ablation device 166 itself can be used to steer the distal end of the device 166 into position to the desired treatment site.


Once in position, an electrically conductive fluid is then injected into the balloon 174, causing the balloon 174 to inflate (block 202). If necessary, the switch 190 on the RF generator 34 can then be set to activate the first (i.e., balloon) electrode 184 (block 204), causing energy to flow from the electrode 184 to the distal conductive section 196b of the balloon 174 through conduction through the fluid and balloon material. The clinician may then form a relatively wide lesion on the tissue by contacting the distal section 196b of the balloon 174 with the tissue (block 206).


The size and shape of the distal balloon section 196b produces a lesion that is very uniform in nature and is void of dehydrated or charred areas that can result in catheters that use an electrode in direct contact with the tissue to be ablated. In some procedures, the size and shape of the inflated balloon 174 can also facilitate forming overlapping lesions to ensure a contiguous ablation line is created and that the aberrant electrical conduction is completely blocked. In those embodiments in which the distal section 196b is also porous, a steady flow of electrically conductive fluid can be maintained throughout the ablation period, which further serves to create an electrical pathway between the balloon 174 and the body tissue.


If, during the ablation procedure, the operator desires to provide a pin-point lesion on the tissue, the switch 190 can then be set to operate using the second electrode 186 (block 208). Once set, the energy from the RF generator 34 is then transmitted to the second (i.e., tip) electrode 186, which directs RF energy directly into the tissue. In contrast to the first electrode 184, which has a relatively large surface area in contact with the tissue to be ablated, the second electrode 186 produces a smaller, focused ablation (block 210). In certain procedures, for example, the second electrode 186 can be used to generate narrow, focused ablation points whereas the first electrode 184 can be used to generate wider, less-focused ablation points. The process of switching back and forth between each of the electrodes 184, 186 can be repeated one or more times until the ablation procedure is complete.


Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.

Claims
  • 1. An ablation device for treating body tissue, comprising: an elongate shaft having a proximal section, a distal section, and at least one fluid lumen configured to receive an electrically conductive fluid;an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the at least one fluid lumen for actuating the balloon between a collapsed state and an expanded state, wherein the balloon comprises a composite structure having a proximal balloon section including a first polymeric material and a distal balloon section including a second polymeric material different from the first material, and the first polymeric material is a hydrophobic polymer and the second polymeric material is a hydrophilic polymer; andat least one electrode located within the interior space of the balloon.
  • 2. The ablation device of claim 1, further comprising at least one additional fluid lumen for recirculating fluid through the device.
  • 3. The ablation device of claim 1, wherein, in the expanded state, the balloon is conically shaped.
  • 4. The ablation device of claim 1, wherein the distal section of the balloon is invaginated.
  • 5. The ablation device of claim 1, wherein the distal section of the balloon is semi-permeable.
  • 6. The ablation device of claim 1, wherein a thickness of the balloon tapers along a length of the balloon from the proximal balloon section to the distal balloon section.
  • 7. The ablation device of claim 1, wherein the balloon comprises a multi-layered structure.
  • 8. The ablation device of claim 1, further comprising a temperature sensing element coupled to the distal section of the balloon.
  • 9. The ablation device of claim 1, further comprising at least one electrocardiogram sensor coupled to the distal section of the balloon.
  • 10. The ablation device of claim 1, further comprising a spring-actuated plunger assembly configured to bias the balloon in the collapsed state.
  • 11. The ablation device of claim 10, wherein the plunger assembly comprises a plunger mechanism and a spring configured to bias the plunger mechanism against the balloon.
  • 12. The ablation device of claim 11, wherein the plunger mechanism includes a plunger shaft and an atraumatic tip.
  • 13. The ablation device of claim 12, wherein the plunger shaft is slidably disposed within the elongate shaft and the electrode.
  • 14. An ablation device for treating body tissue, comprising: an elongate shaft having a proximal section, a distal section, and at least one fluid lumen configured to receive an electrically conductive fluid;an inflatable balloon coupled to the distal section of the shaft and including an interior section in fluid communication with the at least one fluid lumen for actuating the balloon between a collapsed state and an expanded state;at least one electrode located within the interior space of the balloon; anda spring-actuated plunger assembly configured to bias the balloon in the collapsed state, the plunger assembly including a plunger mechanism and a spring configured to bias the plunger mechanism against the balloon, the plunger mechanism including a plunger shaft and an atraumatic tip, wherein the atraumatic tip is configured to disengage from the balloon in the expanded state.
CROSS-REFERENCE TO RELATED APPLICATION

This application claims priority to U.S. Provisional Application No. 61/534,587, filed Sep. 14, 2011, which is herein incorporated by reference in its entirety. This application is related to U.S. Provisional Application No. 61/534,590, entitled “Ablation Device With Multiple Ablation Modes,” filed on Sep. 14, 2011. The content of this related application is incorporated herein by reference in its entirety for all purposes.

US Referenced Citations (446)
Number Name Date Kind
3773401 Douklias et al. Nov 1973 A
4466443 Utsugi Aug 1984 A
4602624 Naples et al. Jul 1986 A
4633882 Matsuo et al. Jan 1987 A
4732149 Sutter Mar 1988 A
4763660 Kroll et al. Aug 1988 A
4966145 Kikumoto et al. Oct 1990 A
5019076 Yamanashi et al. May 1991 A
5029588 Yock et al. Jul 1991 A
5178150 Silverstein et al. Jan 1993 A
5217460 Knoepfler Jun 1993 A
5238004 Sahatjian et al. Aug 1993 A
5240003 Lancee et al. Aug 1993 A
5254088 Lundquist et al. Oct 1993 A
5295482 Clare et al. Mar 1994 A
5318589 Lichtman Jun 1994 A
5324284 Imran Jun 1994 A
5331966 Bennett et al. Jul 1994 A
5334193 Nardella Aug 1994 A
5341807 Nardella Aug 1994 A
5377685 Kazi et al. Jan 1995 A
5383874 Jackson et al. Jan 1995 A
5385146 Goldreyer Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5391199 Ben-Haim Feb 1995 A
5398683 Edwards et al. Mar 1995 A
5423811 Imran et al. Jun 1995 A
5447529 Marchlinski et al. Sep 1995 A
5462521 Brucker et al. Oct 1995 A
5482054 Slater et al. Jan 1996 A
5485849 Panescu et al. Jan 1996 A
5494042 Panescu et al. Feb 1996 A
5500012 Brucker et al. Mar 1996 A
5520683 Subramaniam et al. May 1996 A
5571088 Lennox et al. Nov 1996 A
5573535 Viklund Nov 1996 A
5575772 Lennox Nov 1996 A
5579764 Goldreyer Dec 1996 A
5582609 Swanson et al. Dec 1996 A
5647870 Kordis et al. Jul 1997 A
5718701 Shai et al. Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5762067 Dunham et al. Jun 1998 A
5788636 Curley Aug 1998 A
5792064 Panescu et al. Aug 1998 A
5800482 Pomeranz et al. Sep 1998 A
5820568 Willis Oct 1998 A
5830213 Panescu et al. Nov 1998 A
5833621 Panescu et al. Nov 1998 A
5836990 Li Nov 1998 A
5868735 Lafontaine Feb 1999 A
5871483 Jackson Feb 1999 A
5871526 Gibbs et al. Feb 1999 A
5876336 Swanson et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5913856 Chia et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5957850 Marian et al. Sep 1999 A
6004269 Crowley et al. Dec 1999 A
6027500 Buckles et al. Feb 2000 A
6050267 Nardella et al. Apr 2000 A
6050994 Sherman Apr 2000 A
6059778 Sherman May 2000 A
6063078 Wittkampf May 2000 A
6064905 Webster, Jr. et al. May 2000 A
6068629 Haissaguerre et al. May 2000 A
6070094 Swanson et al. May 2000 A
6083170 Ben-Haim Jul 2000 A
6083222 Klein et al. Jul 2000 A
6099524 Lipson et al. Aug 2000 A
6101409 Swanson et al. Aug 2000 A
6116027 Smith et al. Sep 2000 A
6120476 Fung et al. Sep 2000 A
6165123 Thompson Dec 2000 A
6171305 Sherman Jan 2001 B1
6200314 Sherman Mar 2001 B1
6206831 Suorsa et al. Mar 2001 B1
6210337 Dunham et al. Apr 2001 B1
6216027 Willis et al. Apr 2001 B1
6224557 Ziel et al. May 2001 B1
6233491 Kordis et al. May 2001 B1
6241754 Swanson et al. Jun 2001 B1
6270493 Lalonde et al. Aug 2001 B1
6290697 Tu et al. Sep 2001 B1
6352534 Paddock et al. Mar 2002 B1
6400981 Govari Jun 2002 B1
6423002 Hossack Jul 2002 B1
6475213 Whayne Nov 2002 B1
6488678 Sherman Dec 2002 B2
6491710 Satake Dec 2002 B2
6508767 Burns et al. Jan 2003 B2
6508769 Bonnefous Jan 2003 B2
6508803 Horikawa et al. Jan 2003 B1
6516667 Broad et al. Feb 2003 B1
6517533 Swaminathan Feb 2003 B1
6517534 McGovern et al. Feb 2003 B1
6537271 Murray et al. Mar 2003 B1
6544175 Newman Apr 2003 B1
6546270 Goldin et al. Apr 2003 B1
6547788 Maguire et al. Apr 2003 B1
6569160 Goldin et al. May 2003 B1
6572547 Miller et al. Jun 2003 B2
6575966 Lane et al. Jun 2003 B2
6575969 Rittman et al. Jun 2003 B1
6579278 Bencini Jun 2003 B1
6582372 Poland Jun 2003 B2
6584345 Govari Jun 2003 B2
6589182 Loftman et al. Jul 2003 B1
6592525 Miller et al. Jul 2003 B2
6602242 Fung et al. Aug 2003 B1
6620103 Bruce et al. Sep 2003 B1
6632179 Wilson et al. Oct 2003 B2
6638222 Chandrasekaran et al. Oct 2003 B2
6640120 Swanson et al. Oct 2003 B1
6647281 Morency Nov 2003 B2
6656174 Hegde et al. Dec 2003 B1
6658279 Swanson et al. Dec 2003 B2
6663573 Goldin Dec 2003 B2
6666862 Jain et al. Dec 2003 B2
6676606 Simpson et al. Jan 2004 B2
6692441 Poland et al. Feb 2004 B1
6705992 Gatzke Mar 2004 B2
6709396 Flesch et al. Mar 2004 B2
6711429 Gilboa et al. Mar 2004 B1
6719756 Muntermann Apr 2004 B1
6735465 Panescu May 2004 B2
6736814 Manna et al. May 2004 B2
6743174 Ng et al. Jun 2004 B2
6773402 Govari et al. Aug 2004 B2
6776758 Peszynski et al. Aug 2004 B2
6796979 Lentz Sep 2004 B2
6796980 Hall Sep 2004 B2
6804545 Fuimaono et al. Oct 2004 B2
6811550 Holland et al. Nov 2004 B2
6824517 Salgo et al. Nov 2004 B2
6837884 Woloszko Jan 2005 B2
6845257 Fuimaono et al. Jan 2005 B2
6845264 Skladnev et al. Jan 2005 B1
6917834 Koblish et al. Jul 2005 B2
6922579 Taimisto et al. Jul 2005 B2
6923808 Taimisto Aug 2005 B2
6932811 Hooven et al. Aug 2005 B2
6945938 Grunwald Sep 2005 B2
6950689 Willis et al. Sep 2005 B1
6952615 Satake Oct 2005 B2
6958040 Oliver et al. Oct 2005 B2
7001383 Keidar Feb 2006 B2
7037264 Poland May 2006 B2
7047068 Haissaguerre May 2006 B2
7097643 Cornelius et al. Aug 2006 B2
7099711 Fuimaono et al. Aug 2006 B2
7105122 Karason Sep 2006 B2
7112198 Satake Sep 2006 B2
7115122 Swanson et al. Oct 2006 B1
7123951 Fuimaono et al. Oct 2006 B2
7131947 Demers Nov 2006 B2
7166075 Varghese et al. Jan 2007 B2
7181262 Fuimaono et al. Feb 2007 B2
7220233 Nita et al. May 2007 B2
7232433 Schlesinger et al. Jun 2007 B1
7247155 Hoey et al. Jul 2007 B2
7270634 Scampini et al. Sep 2007 B2
7288088 Swanson Oct 2007 B2
7291142 Eberl et al. Nov 2007 B2
7306561 Sathyanarayana Dec 2007 B2
7335052 D'Sa Feb 2008 B2
7347820 Bonnefous Mar 2008 B2
7347821 Dkyba et al. Mar 2008 B2
7347857 Anderson et al. Mar 2008 B2
7361144 Levrier et al. Apr 2008 B2
7422591 Phan Sep 2008 B2
7438714 Phan Oct 2008 B2
7455669 Swanson Nov 2008 B2
7488289 Suorsa et al. Feb 2009 B2
7507205 Borovsky et al. Mar 2009 B2
7519410 Taimisto et al. Apr 2009 B2
7529393 Peszynski et al. May 2009 B2
7534207 Shehada et al. May 2009 B2
7544164 Knowles et al. Jun 2009 B2
7549988 Eberl et al. Jun 2009 B2
7569052 Phan et al. Aug 2009 B2
7578791 Rafter Aug 2009 B2
7582083 Swanson Sep 2009 B2
7585310 Phan et al. Sep 2009 B2
7610073 Fuimaono et al. Oct 2009 B2
7648462 Jenkins et al. Jan 2010 B2
7697972 Verard et al. Apr 2010 B2
7704208 Thiele Apr 2010 B2
7720420 Kajita May 2010 B2
7727231 Swanson Jun 2010 B2
7736362 Eberl et al. Jun 2010 B2
7740629 Anderson et al. Jun 2010 B2
7758508 Thiele et al. Jul 2010 B1
7766833 Lee et al. Aug 2010 B2
7776033 Swanson Aug 2010 B2
7785324 Eberl Aug 2010 B2
7794398 Salgo Sep 2010 B2
7796789 Salgo et al. Sep 2010 B2
7799025 Wellman Sep 2010 B2
7815572 Loupas Oct 2010 B2
7819863 Eggers et al. Oct 2010 B2
7837624 Hossack et al. Nov 2010 B1
7859170 Knowles et al. Dec 2010 B2
7862561 Swanson et al. Jan 2011 B2
7862562 Eberl Jan 2011 B2
7879029 Jimenez Feb 2011 B2
7892228 Landis et al. Feb 2011 B2
7894871 Wittkampf et al. Feb 2011 B2
7918850 Govari et al. Apr 2011 B2
7957817 Gillespie et al. Jun 2011 B1
7996085 Levin Aug 2011 B2
8016822 Swanson Sep 2011 B2
8103327 Harlev et al. Jan 2012 B2
8128617 Bencini et al. Mar 2012 B2
8160690 Wilfley et al. Apr 2012 B2
8162935 Paul et al. Apr 2012 B2
8265745 Hauck et al. Sep 2012 B2
8267926 Paul et al. Sep 2012 B2
8290578 Schneider Oct 2012 B2
8317783 Cao et al. Nov 2012 B2
8369922 Paul et al. Feb 2013 B2
8400164 Osadchy et al. Mar 2013 B2
8403925 Miller et al. Mar 2013 B2
8406866 Deno et al. Mar 2013 B2
8414579 Kim et al. Apr 2013 B2
8449535 Deno et al. May 2013 B2
8454538 Wittkampf et al. Jun 2013 B2
8454589 Deno et al. Jun 2013 B2
8489184 Wilfley et al. Jul 2013 B2
8579889 Bencini Nov 2013 B2
8583215 Lichtenstein Nov 2013 B2
8603084 Fish et al. Dec 2013 B2
8603085 Jimenez Dec 2013 B2
8644950 Hauck Feb 2014 B2
8657814 Werneth et al. Feb 2014 B2
8672936 Thao et al. Mar 2014 B2
8679109 Paul et al. Mar 2014 B2
8728077 Paul et al. May 2014 B2
8740900 Kim et al. Jun 2014 B2
8755860 Paul et al. Jun 2014 B2
8894643 Watson et al. Nov 2014 B2
8906011 Gelbart et al. Dec 2014 B2
8945015 Rankin et al. Feb 2015 B2
8998890 Paul et al. Apr 2015 B2
9089340 Hastings et al. Jul 2015 B2
9125565 Hauck Sep 2015 B2
9125668 Subramaniam et al. Sep 2015 B2
9173586 Deno et al. Nov 2015 B2
9211156 Kim et al. Dec 2015 B2
9241687 McGee Jan 2016 B2
9254163 Paul et al. Feb 2016 B2
9271782 Paul et al. Mar 2016 B2
9283026 Paul et al. Mar 2016 B2
9393072 Kim et al. Jul 2016 B2
20010029371 Kordis Oct 2001 A1
20020087208 Koblish et al. Jul 2002 A1
20020165448 Ben-Haim et al. Nov 2002 A1
20020198521 Maguire Dec 2002 A1
20030013958 Govari et al. Jan 2003 A1
20030088240 Saadat May 2003 A1
20030158548 Phan et al. Aug 2003 A1
20030158549 Swanson Aug 2003 A1
20030229286 Lenker Dec 2003 A1
20040006268 Gilboa et al. Jan 2004 A1
20040082860 Haissaguerre Apr 2004 A1
20040092806 Sagon et al. May 2004 A1
20040116793 Taimisto et al. Jun 2004 A1
20040147920 Keidar Jul 2004 A1
20040162556 Swanson Aug 2004 A1
20040186467 Swanson et al. Sep 2004 A1
20040210136 Varghese et al. Oct 2004 A1
20040215177 Swanson Oct 2004 A1
20040215186 Cornelius et al. Oct 2004 A1
20050033331 Burnett et al. Feb 2005 A1
20050059862 Phan Mar 2005 A1
20050059962 Phan Mar 2005 A1
20050059963 Phan et al. Mar 2005 A1
20050059965 Eberl Mar 2005 A1
20050065506 Phan Mar 2005 A1
20050065508 Johnson et al. Mar 2005 A1
20050070894 McClurken Mar 2005 A1
20050090817 Phan Apr 2005 A1
20050119545 Swanson Jun 2005 A1
20050119648 Swanson Jun 2005 A1
20050119649 Swanson Jun 2005 A1
20050119653 Swanson Jun 2005 A1
20050119654 Swanson et al. Jun 2005 A1
20050124881 Kanai et al. Jun 2005 A1
20050187544 Swanson et al. Aug 2005 A1
20050203597 Yamazaki Sep 2005 A1
20050228286 Messerly et al. Oct 2005 A1
20050228504 Demarais Oct 2005 A1
20050273060 Levy et al. Dec 2005 A1
20060030919 Mrva et al. Feb 2006 A1
20060089634 Anderson et al. Apr 2006 A1
20060100522 Yuan et al. May 2006 A1
20060161146 Cornelius et al. Jul 2006 A1
20060247607 Cornelius et al. Nov 2006 A1
20060247683 Danek et al. Nov 2006 A1
20060253028 Lam et al. Nov 2006 A1
20060253116 Avitall et al. Nov 2006 A1
20070003811 Zerfass et al. Jan 2007 A1
20070016054 Yuan et al. Jan 2007 A1
20070016059 Morimoto et al. Jan 2007 A1
20070016228 Salas Jan 2007 A1
20070021744 Creighton Jan 2007 A1
20070049925 Phan et al. Mar 2007 A1
20070055225 Dodd, III et al. Mar 2007 A1
20070073135 Lee et al. Mar 2007 A1
20070088345 Larson et al. Apr 2007 A1
20070165916 Cloutier et al. Jul 2007 A1
20070167813 Lee et al. Jul 2007 A1
20070181139 Hauck Aug 2007 A1
20070238997 Camus Oct 2007 A1
20070270794 Anderson et al. Nov 2007 A1
20080009733 Saksena Jan 2008 A1
20080015568 Paul et al. Jan 2008 A1
20080025145 Peszynski et al. Jan 2008 A1
20080051841 Swerdlow et al. Feb 2008 A1
20080058836 Moll et al. Mar 2008 A1
20080086073 McDaniel Apr 2008 A1
20080091109 Abraham Apr 2008 A1
20080140065 Rioux et al. Jun 2008 A1
20080161705 Podmore et al. Jul 2008 A1
20080161795 Wang et al. Jul 2008 A1
20080161796 Cao et al. Jul 2008 A1
20080195089 Thiagalingam et al. Aug 2008 A1
20080228111 Nita Sep 2008 A1
20080243214 Koblish Oct 2008 A1
20080275428 Tegg et al. Nov 2008 A1
20080281322 Sherman et al. Nov 2008 A1
20080287803 Li et al. Nov 2008 A1
20080300454 Goto Dec 2008 A1
20080312521 Solomon Dec 2008 A1
20080312713 Wilfley et al. Dec 2008 A1
20090005771 Lieber et al. Jan 2009 A1
20090030312 Hadjicostis Jan 2009 A1
20090048591 Ibrahim et al. Feb 2009 A1
20090056344 Poch Mar 2009 A1
20090062790 Malchano et al. Mar 2009 A1
20090062795 Vakharia et al. Mar 2009 A1
20090076390 Lee et al. Mar 2009 A1
20090093810 Subramaniam et al. Apr 2009 A1
20090093811 Koblish et al. Apr 2009 A1
20090099472 Remmert et al. Apr 2009 A1
20090131932 Vakharia et al. May 2009 A1
20090163904 Miller et al. Jun 2009 A1
20090171341 Pope et al. Jul 2009 A1
20090171345 Miller et al. Jul 2009 A1
20090177069 Razavi Jul 2009 A1
20090177111 Miller et al. Jul 2009 A1
20090182316 Bencini Jul 2009 A1
20090209950 Starksen Aug 2009 A1
20090216125 Lenker Aug 2009 A1
20090240247 Rioux et al. Sep 2009 A1
20090259274 Simon et al. Oct 2009 A1
20090275827 Aiken et al. Nov 2009 A1
20090281541 Ibrahim et al. Nov 2009 A1
20090287202 Ingle et al. Nov 2009 A1
20090292209 Hadjicostis Nov 2009 A1
20090299355 Bencini et al. Dec 2009 A1
20090299360 Ormsby Dec 2009 A1
20090306643 Pappone et al. Dec 2009 A1
20100010487 Phan et al. Jan 2010 A1
20100057072 Roman et al. Mar 2010 A1
20100076402 Mazzone Mar 2010 A1
20100094274 Narayan et al. Apr 2010 A1
20100106155 Anderson et al. Apr 2010 A1
20100113938 Park et al. May 2010 A1
20100145221 Brunnett et al. Jun 2010 A1
20100152728 Park et al. Jun 2010 A1
20100168557 Deno et al. Jul 2010 A1
20100168568 Sliwa Jul 2010 A1
20100168570 Sliwa et al. Jul 2010 A1
20100168831 Korivi et al. Jul 2010 A1
20100241117 Paul et al. Sep 2010 A1
20100249599 Hastings et al. Sep 2010 A1
20100249603 Hastings et al. Sep 2010 A1
20100249604 Hastings et al. Sep 2010 A1
20100298826 Leo et al. Nov 2010 A1
20100331658 Kim et al. Dec 2010 A1
20110028820 Lau et al. Feb 2011 A1
20110034915 Ibrahim et al. Feb 2011 A1
20110071400 Hastings et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110112569 Friedman et al. May 2011 A1
20110125143 Gross et al. May 2011 A1
20110130648 Beeckler et al. Jun 2011 A1
20110137153 Govari et al. Jun 2011 A1
20110144491 Sliwa et al. Jun 2011 A1
20110144524 Fish et al. Jun 2011 A1
20110160584 Paul et al. Jun 2011 A1
20110237933 Cohen Sep 2011 A1
20110282249 Tsoref et al. Nov 2011 A1
20110319782 Sweeney et al. Dec 2011 A1
20120004547 Harks et al. Jan 2012 A1
20120095347 Adam et al. Apr 2012 A1
20120101398 Ramanathan et al. Apr 2012 A1
20120116537 Liebetanz May 2012 A1
20120136346 Condie et al. May 2012 A1
20120136348 Condie et al. May 2012 A1
20120136351 Weekamp et al. May 2012 A1
20120172698 Hastings et al. Jul 2012 A1
20120172727 Hastings et al. Jul 2012 A1
20120172871 Hastings et al. Jul 2012 A1
20120238897 Wilfley et al. Sep 2012 A1
20120310064 McGee Dec 2012 A1
20120330304 Vegesna et al. Dec 2012 A1
20130023784 Schneider et al. Jan 2013 A1
20130023897 Wallace Jan 2013 A1
20130060245 Grunewald et al. Mar 2013 A1
20130066312 Subramaniam et al. Mar 2013 A1
20130066315 Subramaniam et al. Mar 2013 A1
20130172715 Just et al. Jul 2013 A1
20130172742 Rankin et al. Jul 2013 A1
20130184706 Gelbart et al. Jul 2013 A1
20130190747 Koblish et al. Jul 2013 A1
20130197363 Rankin et al. Aug 2013 A1
20130226169 Miller et al. Aug 2013 A1
20130274582 Afonso et al. Oct 2013 A1
20130331739 Gertner Dec 2013 A1
20140012251 Himmelstein et al. Jan 2014 A1
20140058375 Koblish Feb 2014 A1
20140066764 Subramaniam et al. Mar 2014 A1
20140073893 Bencini Mar 2014 A1
20140075753 Haarer et al. Mar 2014 A1
20140081111 Tun et al. Mar 2014 A1
20140081112 Kim et al. Mar 2014 A1
20140081113 Cohen et al. Mar 2014 A1
20140081262 Koblish et al. Mar 2014 A1
20140107453 Maskara et al. Apr 2014 A1
20140107636 Bencini Apr 2014 A1
20140194867 Fish et al. Jul 2014 A1
20140214028 Gelbart et al. Jul 2014 A1
20140228713 Thao et al. Aug 2014 A1
20140276052 Rankin et al. Sep 2014 A1
20140276811 Koblish Sep 2014 A1
20140364843 Paul et al. Dec 2014 A1
20150011995 Avitall et al. Jan 2015 A1
20150133914 Koblish May 2015 A1
20150133920 Rankin et al. May 2015 A1
20150265341 Koblish Sep 2015 A1
20150265348 Avitall et al. Sep 2015 A1
20150342672 Bencini et al. Dec 2015 A1
20150374436 Subramaniam et al. Dec 2015 A1
20160100884 Fay et al. Apr 2016 A1
Foreign Referenced Citations (81)
Number Date Country
2682055 Oct 2008 CA
1269708 Oct 2000 CN
1455655 Nov 2003 CN
1942145 Apr 2007 CN
102271607 Dec 2011 CN
102573986 Jul 2012 CN
104619259 May 2015 CN
104640513 May 2015 CN
104661609 May 2015 CN
1343426 Sep 2003 EP
1343427 Sep 2003 EP
1502542 Feb 2005 EP
1547537 Jun 2005 EP
0985423 Apr 2006 EP
1717601 Nov 2006 EP
1935332 Jun 2008 EP
2136702 Jul 2015 EP
2000000242 Jan 2000 JP
200083918 Mar 2000 JP
2000504242 Apr 2000 JP
2002528039 Aug 2002 JP
2003504090 Feb 2003 JP
2004503335 Feb 2004 JP
2006239414 Sep 2006 JP
2007163559 Jun 2007 JP
2007244857 Sep 2007 JP
2009142653 Dec 2008 JP
2009518150 May 2009 JP
2010522623 Jul 2010 JP
2011142995 Jul 2011 JP
2011525842 Sep 2011 JP
2012531967 Dec 2012 JP
5336465 Nov 2013 JP
2014012174 Jan 2014 JP
2015509027 Mar 2015 JP
20100021401 Feb 2010 KR
101490374 Feb 2015 KR
WO9221278 Dec 1992 WO
WO9413358 Jun 1994 WO
WO9725916 Jul 1997 WO
WO9725917 Jul 1997 WO
WO9736541 Oct 1997 WO
9745156 Dec 1997 WO
WO9858681 Dec 1998 WO
9909879 Mar 1999 WO
WO9927862 Jun 1999 WO
WO0029062 May 2000 WO
WO0158372 Aug 2001 WO
WO0164145 Sep 2001 WO
WO0168173 Sep 2001 WO
WO0205868 Jan 2002 WO
WO0209599 Feb 2002 WO
WO0219934 Mar 2002 WO
WO0247569 Jun 2002 WO
WO02102234 Dec 2002 WO
WO03039338 May 2003 WO
WO2007079278 Jul 2007 WO
WO2008046031 Apr 2008 WO
WO2008118992 Oct 2008 WO
WO2009032421 Mar 2009 WO
2009048824 Apr 2009 WO
2010054409 May 2010 WO
WO2010056771 May 2010 WO
2010082146 Jul 2010 WO
2011008444 Jan 2011 WO
2011033421 Mar 2011 WO
WO2011024133 Mar 2011 WO
WO2011089537 Jul 2011 WO
2011101778 Aug 2011 WO
WO2011095937 Aug 2011 WO
2012001595 Jan 2012 WO
WO2012001595 Jan 2012 WO
WO2012049621 Apr 2012 WO
WO2012066430 May 2012 WO
2012161880 Nov 2012 WO
WO2012151301 Nov 2012 WO
2012166239 Dec 2012 WO
2014072879 May 2014 WO
2014152575 Sep 2014 WO
2015143061 Sep 2015 WO
2015183635 Dec 2015 WO
Non-Patent Literature Citations (45)
Entry
Extended European Search Report issued in EP Application No. 15174537.9, issued Mar. 2, 2016, 7 pages.
Goldberg, S. Nahum et al., “Variables Affecting Proper System Grounding for Radiofrequency Ablation in an Animal Model”, JVIR, vol. 11, No. 8, Sep. 2000, pp. 1069-1075.
Haverkamp, W., et. al. Coagulation of Ventricular Myocardium Using Radiofrequency Alternating Current: Bio-Physical Aspects and Experimental Findings. PACE, 12:187-195, Jan. 1989, Part II.
International Preliminary Examination Report issued in PCT/US2013/060612, completed Mar. 24, 2015, 10 pages.
International Preliminary Report on Patentability issued in PCT/US2008/058324, mailed Sep. 29, 2009, 9 pages.
International Preliminary Report on Patentability issued in PCT/US2013/058105, completed Mar. 10, 2015.
International Preliminary Report on Patentability issued in PCT/US2014/027491, mailed Sep. 24, 2015, 12 pages.
International Search Report and Written Opinion issued in PCT/US2008/058324, dated Aug. 18, 2008, 11 pages.
International Search Report and Written Opinion issued in PCT/US2012/031819, mailed Sep. 27, 2012, 16 pages.
International Search Report and Written Opinion issued in PCT/US2012/072061, mailed Mar. 21, 2013, 9 pages.
International Search Report and Written Opinion issued in PCT/US2013/020503, mailed Mar. 20, 2013, 10 pages.
International Search Report and Written Opinion issued in PCT/US2013/021013, mailed Apr. 5, 2013, 14 pages.
International Search Report and Written Opinion issued in PCT/US2013/056211, mailed Jan. 20, 2014.
International Search Report and Written Opinion issued in PCT/US2013/058105, mailed Nov. 22, 2013, 16 pages.
International Search Report and Written Opinion issued in PCT/US2013/060183, mailed Jan. 27, 2014, 10 pages.
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014.
International Search Report and Written Opinion issued in PCT/US2013/060194, mailed Jan. 29, 2014, 10 pages.
International Search Report and Written Opinion issued in PCT/US2013/060612, mailed Feb. 28, 2014, 16 pages.
International Search Report and Written Opinion issued in PCT/US2014/027491, mailed Sep. 23, 2014, 17 pages.
International Search Report and Written Opinion issued in PCT/US2015/021300, mailed Jun. 9, 2015, 11 pages.
International Search Report and Written Opinion issued in PCT/US2015/055173, mailed Jan. 18, 2016, 11 pages.
International Search Report and Written Opinion issued in PCT/US2015/057242, mailed Jan. 15, 2016, 11 pages.
International Search Report and Written Opinion issued in PCTUS2015/031591, mailed Aug. 17, 2015, 11 pages.
Invitation to Pay Additional Fees and Partial International Search Report issued in PCT/US2014/027491, mailed Jul. 28, 2014, 5 pages.
Machi MD, Junji, “Prevention of Dispersive Pad Skin Burns During RFA by a Simple Method”, Editorial Comment, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 372-373.
Neufeld, Gordon R. et al., “Electrical Impedance Properties of the Body and the Problem of Alternate-site Burns During Electrosurgery”, Medical Instrumentation, vol. 19, No. 2, Mar.-Apr. 1985, pp. 83-87.
Patriciu, A. et al., “Detecting Skin Burns Induced by Surface Electrodes”, published in Engineering in Medicine and Biology Society, 2001. Proceedings of the 23rd Annual International Conference of the IEEE, vol. 3, pp. 3129-3131.
Piorkowski, Christopher et al., “First in Human Validation of Impedance-Based Catheter Tip-to-Tissue Contact Assessment in the Left Atrium”, Journal of Cardiovascular Electrophysiology, vol. 20, No. 12, Dec. 1, 2009, pp. 1366-1373.
Pires, L. A., et. al. Temperature-guided Radiofrequency Catheter Ablation of Closed-Chest Ventricular Myocardium with a Novel Thermistor-Tipped Catheter. American Heart Journal, 127(6):1614-1618, Jun. 1994.
Price, Adam et al., “Novel Ablation Catheter Technology that Improves Mapping Resolution and Monitoring of Lesion Maturation”, The Journal of Innovations in Cardiac Rhythm Management, vol. 3, 2002, pp. 599-609.
Price, Adam et al., “PO3-39 Pin Electrodes Improve Resolution: Enhanced Monitoring of Radiofrequency Lesions in the Voltage and Frequency Domains”, Heart Rhythm 2010, 31st Annual Scientific Sessions, May 12-15 in Denver Colorado.
Ring, E. R., et. al. Catheter Ablation of the Ventricular Septum with Radiofrequency Energy. American Heart Journal, 117(6):1233-1240, Jun. 1989.
Steinke, Karin et al., “Dispersive Pad Site burns With Modern Radiofrequency Ablation Equipment”, Surg Laparosc Endosc Percutan Tech, vol. 13, No. 6, Dec. 2003, pp. 366-371.
Zachary, J.M. et al., “PO4-86 Pin Electrodes Provide Enhanced Resolution Enabling Titration of Radiofrequency Duration to Lesion Maturation”, Heart Rythm 2011, 32 Annual Scientific Sessions, May 4-7, San Francisco, CA.
International Preliminary Examination Report issued in PCT/US2013/060183, completed Mar. 24, 2015, 6 pages.
International Preliminary Report on Patentabiiity issued in PCT/US2013/056211, completed Feb. 24, 2015, 5 pages.
International Preliminary Report on Patentability issued in PCT/US2013/060194, mailed Mar. 24, 2015, 6 pages.
International Search Report and Written Opinion issued in PCT/US2012/055309, mailed Nov. 19, 2012, 13 pages.
Partial International Search Report issued in PCT/US2012/0551545, mailed Dec. 20, 2012, 7 pages.
International Preliminary Report on Patentability issued in PCT/US2012/055155, issued Mar. 18, 2014, 11 pages.
International Preliminary Report on Patentability issued in PCT/US2012/055309, issued on Mar. 18, 2014, 8 pages.
International Search Report and Written Opinion issued in PCT/US2012/055155, mailed Mar. 11, 2013, 19 pages.
International Preliminary Report on Patentability issued in PCT/US2015/021300 mailed Sep. 29, 2016, 7 pages.
International Search Report and Written Opinion issued in PCT/US2015/066674, mailed Apr. 1, 2016, 11 pages.
International Search Report and Written Opinion issued in PCT/US2016/028006 mailed Jul. 12, 2016, 12 pages.
Related Publications (1)
Number Date Country
20130066315 A1 Mar 2013 US
Provisional Applications (1)
Number Date Country
61534587 Sep 2011 US